Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Oxygenation in COPD during One Lung Ventilation
NCT02185430Completed
- Sponsor
- Yonsei University
- Start
- Jul 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of dexmedetomidine in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Yonsei University. Primary endpoint: The change of the oxygenation. Started Jul 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02185430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185430.